{"name":"Retension Pharmaceuticals. Inc.","slug":"retension-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_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?oc=5","date":"2025-08-06","type":"trial","source":"businesswire.com","summary":"Retension Pharmaceuticals Announces Completion of Series B Financing to Advance Phase 2b Trial for Uncontrolled and Resistant Hypertension and Issuance of a New U.S. Patent Covering its Lead Candidate","headline":"Retension Pharmaceuticals Announces Completion of Series B Financing to Advance Phase 2b Trial for Uncontrolled and Resi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxOVHZOZF9kVEdvNm9WdmpQbmVYSEFSTndNMk9sZjR3SnB1LUhOcmYzdkVIMzRoWWUyWjRHeEpaQWE0NTNiNllJTGNyd05pWlFNUm5ENC1UQU9IQmlYMnpEV3ZoLUNReXJ3SExDOE1RQ0F2RjRGVkVEdVBnU0tmdXRlTGRsQkRlMmNYdVFxNDNsakU?oc=5","date":"2025-05-27","type":"pipeline","source":"The Intercept","summary":"Columbia Trustee Got Sued for Securities Fraud — Then Left Her Pharma Firm Under a Cloud - The Intercept","headline":"Columbia Trustee Got Sued for Securities Fraud — Then Left Her Pharma Firm Under a Cloud","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOY1lsZXlEeU9DYTRJdHEzR3RDT1luaUhfbXJEM0EtT2VrODFpMTdNUnFsZE9ZSHZIellXS2xja19hNkpFWE9odHRqcUdKVDVVcVVoQ2k0dzBQcUN0a2hHQ2djcWVuenM0cGFEWEIyV2tSRFNJVUhCWjZ3ZXBrd0xieEtzNEczQ1h0U3dUaDNwSU5xVHluUGpj?oc=5","date":"2024-08-29","type":"pipeline","source":"Falls Church News-Press Online","summary":"Falls Church Business News & Notes: August 29 – September 4, 2024 - Falls Church News-Press Online","headline":"Falls Church Business News & Notes: August 29 – September 4, 2024 - Falls Church News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxOSkhZaWM2VDRZdVdkM2tVN1dBbFVtTm5QaVlEWnNWbndfeEF6YmdTQ0lqRkdkWDdMMmxYVmx0d2dkVHU5eUptckUxZlFxR2ZCZVJmdTk0aWNSSVQ3YXVGbFhud2h0dG1kemtVNU1FSG1TdG9UMjgwVXJQbDVneUJXdk9ONjktQlpQQ2xyaXJPV3ltSUZhQUdNaHRROHNzSGFtRHExTnRjOWU0SlE?oc=5","date":"2024-08-22","type":"pipeline","source":"The Business Journals","summary":"Falls Church biotech spinout raises millions for blood pressure treatment - The Business Journals","headline":"Falls Church biotech spinout raises millions for blood pressure treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwJBVV95cUxQTXZPZkF1VnItOGNsNnZmeTNuRmt3X0pvZG9STWczV3VQNVBLNXR5ZGlCMVBGdzU2WU5JSU5UaU9ma2RaSUlKb3g0SFc1RDhjNGJNS2dJbHNuQ29FUWFMX2x0ZUNPY0VsVjRRRVNBNVMyeWRjc1RxeXdKQ3FRMjhncmk1di1icmtQTjM2d2F3TktVMG83NmhqaXdWa3R2VzlDeS1haTRVZ2J0T0ZDS0xBdndDekw0RUc0b093MUlpRDFqTVVBLVRJbHk2cmliUkZkUGZHRjFhd1Y5LXhPVGNWUFhwSWtsNWpBZTFadjZDOXlOVk15Vk9JcW9uQnJXemUxRXJ0MUZKM2xlbHRodmxBQnVwZU5acFhOaVpuRGFZc2ZTVi1HZjdleGZiTmxIOE5QYU5kd0EweVdWM0hBZnRXd3dnVQ?oc=5","date":"2024-08-21","type":"trial","source":"businesswire.com","summary":"Retension Pharmaceuticals Closes $10.4 Million Oversubscribed Series A to Fund Clinical Trials for Patients Suffering from Resistant and Uncontrolled Hypertension - businesswire.com","headline":"Retension Pharmaceuticals Closes $10.4 Million Oversubscribed Series A to Fund Clinical Trials for Patients Suffering fr","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}